Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the pharmacokinetics, pharmacodynamics, and safety of maraviroc (UK-427,857) in patients with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: COMPLETED